Pressure BioSciences (PBIO) Stock Price, News & Analysis

Company Overview

Pressure BioSciences, Inc. develops pressure-based technologies and instruments for applications in life sciences, food and beverage, nutraceuticals, cosmetics, and other industries. The company’s platforms are designed to use controlled high-pressure processing to improve sample preparation, extraction, formulation, preservation, and the development of consumer and industrial products.

Its product portfolio has included Barocycler high-pressure systems and related consumables for laboratory and research applications. Pressure BioSciences has also focused on its Ultra Shear Technology platform, which uses high-pressure processing to create stable nanoemulsions and other formulations that may support products such as beverages, supplements, cosmetics, and topical formulations.

Founded in 2005 and headquartered in South Easton, Massachusetts, Pressure BioSciences serves research, commercial, and industrial customers. The company has marketed its technologies internationally through direct sales and distribution relationships. Richard T. Schumacher, the company’s founder, has served as its president and chief executive officer.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.20
• Volume: N/A
• Average Volume: 1,464 shs
• Market Capitalization: $8.59 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 2/07/2025
• Today: 9/25/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:PBIO
• CIK: 830656
• Web: www.pressurebiosciences.com
• Phone: 508-230-1828
• Fax: 508-230-1829
• Employees: 16
• Year Founded: 2004

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.98 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 42,970,000
• Free Float: 38,327,000
• Market Cap: $8.59 thousand
• Optionable: Not Optionable
• Beta: 5.76